Tuesday, December 31, 2019

Alkem Labs acquires anti-nausea drug Marinol from AbbVie for $10 million

Alkem Labs acquires anti-nausea drug Marinol from AbbVie for $10 million Marionol capsules are used to treat the loss of appetite (anorexia) in AIDS patients and to treat nausea and vomiting in patients receiving chemotherapy.

from Moneycontrol Business News https://ift.tt/2rGFKLI

No comments:

Post a Comment

BBC announces landmark 'partnership' with YouTube

The BBC has announced a significant deal with YouTube. This partnership will bring British storytelling and news to a wider audience. New co...